161 related articles for article (PubMed ID: 23639779)
1. The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study.
Van Craenenbroeck EM; Conraads VM; Greenlaw N; Gaudesius G; Mori C; Ponikowski P; Anker SD
Eur J Heart Fail; 2013 Jul; 15(7):756-62. PubMed ID: 23639779
[TBL] [Abstract][Full Text] [Related]
2. Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF).
Yeo TJ; Yeo PSD; Hadi FA; Cushway T; Lee KY; Yin FF; Ching A; Li R; Loh SY; Lim SL; Wong RC; Tai BC; Richards AM; Lam CSP
ESC Heart Fail; 2018 Apr; 5(2):344-353. PubMed ID: 29345426
[TBL] [Abstract][Full Text] [Related]
3. Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK.
Gutzwiller FS; Schwenkglenks M; Blank PR; Braunhofer PG; Mori C; Szucs TD; Ponikowski P; Anker SD
Eur J Heart Fail; 2012 Jul; 14(7):782-90. PubMed ID: 22689292
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron supplementation improves energy metabolism of exercising skeletal muscles without effect on either oxidative stress or inflammation in male patients with heart failure with reduced ejection fraction.
Drozd MD; Tkaczyszyn M; Kasztura M; Węgrzynowska-Teodorczyk K; Flinta I; Banasiak W; Ponikowski P; Jankowska EA
Cardiol J; 2024; 31(2):300-308. PubMed ID: 37853824
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.
Ponikowski P; Mentz RJ; Hernandez AF; Butler J; Khan MS; van Veldhuisen DJ; Roubert B; Blackman N; Friede T; Jankowska EA; Anker SD
Eur Heart J; 2023 Dec; 44(48):5077-5091. PubMed ID: 37632415
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.
Richard N; Arab-Hocine N; Vannier M; Leblanc-Boubchir R; Pelaquier A; Boruchowicz A; Musikas M; Amil M; Fumery M; Nahon S; Arotcarena R; Gelsi E; Maurin A; Hébuterne X; Savoye G
Age Ageing; 2024 May; 53(5):. PubMed ID: 38706390
[TBL] [Abstract][Full Text] [Related]
7. Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial.
Santas E; Del Canto I; Cardells I; Miñana G; Llàcer P; Almenar L; Fácila L; Maceira AM; Sanchis J; Núñez J;
ESC Heart Fail; 2024 Apr; 11(2):1258-1262. PubMed ID: 38115745
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of ferric carboxymaltose in pre-operative haemoglobin optimisation in patients undergoing primary knee arthroplasty.
Basora M; Pereira A; Coca M; Tió M; Lozano L
Blood Transfus; 2018 Sep; 16(5):438-442. PubMed ID: 30036177
[TBL] [Abstract][Full Text] [Related]
9. Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemia.
Friedman T; Dann EJ; Bitton-Worms K; Makhoul M; Glam R; Weis A; Tam DY; Bolotin G
Br J Anaesth; 2023 Dec; 131(6):981-988. PubMed ID: 37838604
[TBL] [Abstract][Full Text] [Related]
10. A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status.
Bhandari S; Allgar V; Lamplugh A; Macdougall I; Kalra PA
BMC Nephrol; 2021 Mar; 22(1):115. PubMed ID: 33784968
[TBL] [Abstract][Full Text] [Related]
11. Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.
Macdougall IC; Ponikowski P; Stack AG; Wheeler DC; Anker SD; Butler J; Filippatos G; Göhring UM; Kirwan BA; Kumpeson V; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA
Clin J Am Soc Nephrol; 2023 Sep; 18(9):1124-1134. PubMed ID: 37382961
[TBL] [Abstract][Full Text] [Related]
12. Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
Mentz RJ; Garg J; Rockhold FW; Butler J; De Pasquale CG; Ezekowitz JA; Lewis GD; O'Meara E; Ponikowski P; Troughton RW; Wong YW; She L; Harrington J; Adamczyk R; Blackman N; Hernandez AF;
N Engl J Med; 2023 Sep; 389(11):975-986. PubMed ID: 37632463
[TBL] [Abstract][Full Text] [Related]
13. Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study.
Wahid M; Islam S; Sepehrvand N; Dover DC; McAlister FA; Kaul P; Ezekowitz JA
Circ Heart Fail; 2024 Apr; 17(4):e011351. PubMed ID: 38572652
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction.
Ray R; Ford I; Cleland JGF; Graham F; Ahmed FZ; Al-Mohammad A; Cowburn PJ; Critoph C; Kalra PA; Lane RE; Ludman A; Pellicori P; Petrie MC; Robertson M; Seed A; Squire I; Kalra PR; ; ; ;
J Card Fail; 2024 May; 30(5):682-690. PubMed ID: 37926238
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
Cleland JGF; Kalra PA; Pellicori P; Graham FJ; Foley PWX; Squire IB; Cowburn PJ; Seed A; Clark AL; Szwejkowski B; Banerjee P; Cooke J; Francis M; Clifford P; Wong A; Petrie C; McMurray JJV; Thomson EA; Wetherall K; Robertson M; Ford I; Kalra PR;
Eur Heart J; 2024 Apr; 45(16):1410-1426. PubMed ID: 38446126
[TBL] [Abstract][Full Text] [Related]
16. Early improvement of global longitudinal strain after iron deficiency correction in heart failure with reduced ejection fraction.
Sutil-Vega M; Rizzo M; Colomer-Asenjo Í; Taibi F; Castaldo F; Del Castillo-Vázquez P; Mallofré N; Torres-Ruiz G; Rojas P; Martínez-Rubio A
Echocardiography; 2024 Jan; 41(1):e15726. PubMed ID: 38078698
[TBL] [Abstract][Full Text] [Related]
17. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
Rosano G; Ponikowski P; Vitale C; Anker SD; Butler J; Fabien V; Filippatos G; Kirwan BA; Macdougall IC; Metra M; Ruschitzka F; Kumpeson V; Goehring UM; van der Meer P; Jankowska EA;
Cardiovasc Diabetol; 2023 Aug; 22(1):215. PubMed ID: 37592272
[TBL] [Abstract][Full Text] [Related]
18. Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis.
Khan MS; Usman MS; von Haehling S; Doehner W; Stewart Coats AJ
ESC Heart Fail; 2020 Dec; 7(6):3392-3400. PubMed ID: 33586856
[TBL] [Abstract][Full Text] [Related]
19. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
McDonagh T; Macdougall IC
Eur J Heart Fail; 2015 Mar; 17(3):248-62. PubMed ID: 25639592
[TBL] [Abstract][Full Text] [Related]
20. Anaemia, iron deficiency and heart failure in 2020: facts and numbers.
Chopra VK; Anker SD
ESC Heart Fail; 2020 Oct; 7(5):2007-2011. PubMed ID: 32602663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
